蛋白酪氨酸磷酸酶受體C(CD45)活性蛋白
Active Protein Tyrosine Phosphatase Receptor Type C (CD45)
PTPRC; PTPR-C; LCA; B220; GP180; LY5; T200; Leukocyte common antigen
- 編號(hào)APB030Hu61
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)6.8
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1056 ¥ 2640 ¥ 5280 ¥ 15840 ¥ 39600
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)
Protein Tyrosine Phosphatase Receptor Type C (CD45) is one of the most abundant leukocyte cell surface glycoproteins and is expressed exclusively upon cells of the hematopoietic system. CD45 functions positively to regulate lymphocyte activation by servesing to dephosphorylate and activate members of the Src-tyrosine kinase family. it has been reported that SEMA4D can associate with the phosphatase CD45 at the surface of T cells and that triggering of CD45 on T cells, using monoclonal antibodies (mAb), induces shedding of SEMA4D. Thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human CD45 and recombinant human SEMA4D. Briefly, biotin-linked CD45 were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 ul were then transferred to SEMA4D-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μl stop solution to the wells and read at 450 nm immediately. The binding activity of CD45 and SEMA4D was shown in Figure 1, the EC50?for this effect is 6.47 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB030Hu03 | 蛋白酪氨酸磷酸酶受體C(CD45)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB030Hu01 | 蛋白酪氨酸磷酸酶受體C(CD45)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB030Hu61 | 蛋白酪氨酸磷酸酶受體C(CD45)活性蛋白 | Cell?culture;?Activity?Assays. |
RPB030Hu02 | 蛋白酪氨酸磷酸酶受體C(CD45)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPB030Hu61 | 蛋白酪氨酸磷酸酶受體C(CD45)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB030Hu02 | 蛋白酪氨酸磷酸酶受體C(CD45)多克隆抗體 | WB; IHC; ICC; IP. |
PAB030Hu01 | 蛋白酪氨酸磷酸酶受體C(CD45)多克隆抗體 | WB; IHC; ICC; IP. |
FAB030Hu01 | 抗蛋白酪氨酸磷酸酶受體C(CD45)多克隆抗體 | FCM |
LAB030Hu71 | 蛋白酪氨酸磷酸酶受體C(CD45)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAB030Hu23 | 蛋白酪氨酸磷酸酶受體C(CD45)單克隆抗體 | WB; IHC; ICC; IP. |
MAB030Hu24 | 蛋白酪氨酸磷酸酶受體C(CD45)單克隆抗體 | WB; IHC; ICC; IP. |
RAB030Hu21 | 蛋白酪氨酸磷酸酶受體C(CD45)重組抗體 | WB; IHC; ICC; FCM. |
MAB030Hu22 | 蛋白酪氨酸磷酸酶受體C(CD45)單克隆抗體 | WB; IHC; ICC; IP. |
MAB030Hu21 | 蛋白酪氨酸磷酸酶受體C(CD45)單克隆抗體 | WB; IHC; ICC; IP. |
RAB030Hu22 | 蛋白酪氨酸磷酸酶受體C(CD45)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
RAB030Hu01 | 蛋白酪氨酸磷酸酶受體C(CD45)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
FAB030Hu86 | 抗蛋白酪氨酸磷酸酶受體C(CD45)單克隆抗體(異硫氰酸熒光素標(biāo)記) | FCM |
FAB030Hu34 | 抗蛋白酪氨酸磷酸酶受體C(CD45)單克隆抗體(別藻藍(lán)蛋白/花青染料cy7標(biāo)記) | FCM |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Cell | Size-dependent segregation controls macrophage phagocytosis of antibody-opsonized targets [Pubmed:29958103] |